Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review
eJHaem · 2025-12 · 6 (6)
DOI: 10.1002/jha2.70174 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift eJHaem, online erschienen am 06.11.2025. Verfasst von Phil Choi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Caberra Hospital Canberra Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to assess the burden of warm autoimmune haemolytic anaemia (wAIHA) and treatment practices in the Asia‐Pacific (APAC) region.
Methods
A systematic literature review (SLR) of observational studies in adult patients with wAIHA was conducted. Based on these findings, a Delphi panel was convened to develop consensus recommendations on diagnosis, treatment goals and algorithms by subtypes, unmet needs and research priorities.
Results
The SLR included 37 publications. Clinical guidelines consistently recommend direct antiglobulin testing for diagnosis and corticosteroids as first‐line treatment. Real‐world data showed corticosteroid use in over 80% of patients, with response rates of 81%–96%, and relapse rates of 18%–45%. The Delphi panel recommended routine screening for underlying conditions and early therapeutic interventions. Key challenges identified included restricted access to rituximab in parts of the APAC region and gaps in physician awareness. Research priorities included optimising therapy, assessing long‐term outcomes and improving disease awareness.
Conclusion
This research emphasises the need for evidence‐based, regionally adaptable treatment algorithms for wAIHA in the APAC region. Ongoing data gaps related to epidemiology, outcomes and quality of life must be addressed to enhance patient care. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Caberra Hospital Canberra Australia.
- Department of Rheumatology Monash Health School of Clinical Sciences Monash University Melbourne Australia.
- Department of Hematology General Hospital Tianjin Medical University Tianjin China.
- Samsung Medical Center Seoul South Korea.
- The University of Hong Kong Hong Kong China.
- Tianjin Medical University General Hospital Tianjin China.
ORCID-Profile: Phil Choi, Rong Fu, Jun-Ho Jang, Yasutaka Ueda, Petya Kodjamanova
Zitieren
APA
Choi, P., Hoi, A., Fu, R., Jang, J. H., Kwong, Y. L., Miyakawa, Y., Mok, C. C., Niiro, H., Ueda, Y., Bagnall, R., Kodjamanova, P., Ahn, D. E., Saxena, N., Wahking, B., & Lee, S. S. (2025). Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review. eJHaem, 6(6). https://doi.org/10.1002/jha2.70174
Vancouver
Choi P, Hoi A, Fu R, Jang JH, Kwong YL, Miyakawa Y, et al. Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review. eJHaem. 2025;6(6). doi:10.1002/jha2.70174
BibTeX
@article{Choi2025,
author = {Choi, Phil and Hoi, Alberta and Fu, Rong and Jang, Jun-Ho and Kwong, Yok Lam and Miyakawa, Yoshitaka and Mok, Chi-Chiu and Niiro, Hiroaki and Ueda, Yasutaka and Bagnall, Robert and Kodjamanova, Petya and Ahn, Da Eun and Saxena, Nakul and Wahking, Bryan and Lee, Shin-Seok},
title = {Warm Autoimmune Haemolytic Anaemia Management in Asia‐Pacific: A Delphi Panel Expert Consensus and Systematic Literature Review},
journal = {eJHaem},
year = {2025},
volume = {6},
number = {6},
doi = {10.1002/jha2.70174}
}
EUVIMED